Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.
暂无分享，去创建一个
M. Kassiou | T. Reekie | T. Johns | B. Stringer | R. Ryan | B. Day | J. Font | L. Munoz | M. Hoque | Qingqing Zhou | Ramzi H. Abbassi | A. Phoa | Tristan A. Reekie | Monira Hoque